Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

Cited by (359)

Items 201–300 of 359

1. Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323
   Toshiyuki Kozuki, Naoyuki Nogami, Osamu Hataji, Yoshio Tsunezuka, Nobuhiko Seki, Toshiyuki Harada, Nobukazu Fujimoto, Akihiro Bessho, Kei Takamura, Kazuhisa Takahashi et al. · 2020 · Translational Lung Cancer Research
2. Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper
   Nicolò Matteo Luca Battisti, Gabor Istvan Liposits, Nienke A. de Glas, Fábio Gomes, Capucine Baldini, Supriya Gupta Mohile · 2020 · Current Oncology Reports
3. Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden
   Hirsh Koyi, Gunnar Hillerdal, Olov Andersson, Karl‐Gustav Kölbeck, Per Liv, Eva Brandén · 2015 · Lung Cancer International
4. Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer
   Sung Hoon Sim, Yu Jung Kim, Se Hyun Kim, Bhumsuk Keam, Tae Min Kim, Se‐Hoon Lee, Dong‐Wan Kim, Dae Seog Heo, Jong Seok Lee · 2014 · Journal of Cancer Research and Clinical Oncology
5. Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or more
   Akihiro Tamiya, Tateaki Naito, Akira Ono, Eriko Ayabe, Asuka Tsuya, Yukiko Nakamura, Kyoichi Kaira, Haruyasu Murakami, Toshiaki Takahashi, Masahiro Endo et al. · 2010 · Lung Cancer
6. A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
   Kenzo Soejima, Katsuhiko Naoki, Kota Ishioka, Morio Nakamura, Michie Nakatani, Ichiro Kawada, Hideo Watanabe, Ichiro Nakachi, Hiroyuki Yasuda, Ryosuke Satomi et al. · 2015 · Cancer Chemotherapy and Pharmacology
7. A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202
   Shoichi Kuyama, Nobuaki Ochi, Akihiro Bessho, Katsuyuki Hotta, Genyo Ikeda, Daizo Kishino, Toshio Kubo, Daijiro Harada, Nobukazu Fujimoto, Masamoto Nakanishi et al. · 2017 · Lung Cancer
8. Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer
   J.B. Auliac, Karima Saboundji, Michel Andre, Jeannick Madelaine, Gilles Quéré, Philippe Masson, Alain Vergnenégre, R. Lamy, Stéphane Raymond, Anne-Marie Chiappa et al. · 2019 · Targeted Oncology
9. Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study
   Kosuke Kashiwabara, Shinji Fujii, Shinsuke Tsumura, Kazuhiko Sakamoto · 2020 · Journal of Cancer Research and Clinical Oncology
10. Efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer: A multicenter retrospective cohort study
    Kinnosuke Matsumoto, Akihiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Yoshinobu Matsuda, Hayato Kawachi, Motohiro Tamiya, Satoshi Tanizaki, Junji Uchida, Kiyonobu Ueno et al. · 2021 · Journal of Geriatric Oncology
11. Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer
    Tomoyoshi Takenaka, Eiko Inamasu, Tsukihisa Yoshida, Gouji Toyokawa, Kaname Nosaki, Fumihiko Hirai, Masafumi Yamaguchi, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose · 2015 · Surgery Today
12. Phase I Results of Vinorelbine With Concurrent Radiotherapy in Elderly Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI)
    Hideyuki Harada, Takashi Seto, Satoshi Igawa, Asuka Tsuya, Mayuko Wada, Kyoichi Kaira, Tateaki Naito, Kazushige Hayakawa, Tetsuo Nishimura, Noriyuki Masuda et al. · 2011 · International Journal of Radiation Oncology*Biology*Physics
13. Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.
    Yifei Zhang, Zhiwei Chen, Shun Lu · 2009 · PubMed
14. Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer
    Kamila Bakirhan, Janaki Neela Sharma, Roman Perez-Soler, Haiying Cheng · 2016 · Current Treatment Options in Oncology
15. Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer
    Shinnosuke Takemoto, Yoichi Nakamura, Minoru Fukuda, Hiroaki Senju, Hiroshi Gyotoku, Hirokazu Taniguchi, Midori Shimada, Takaya Ikeda, Hiroyuki Yamaguchi, Katsumi Nakatomi et al. · 2017 · Thoracic Cancer
16. Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations
    Yutaka Yamada, Hisao Imai, Tomohide Sugiyama, Hiroyuki Minemura, Kenya Kanazawa, Takashi Kasai, Koichi Minato, Kyoichi Kaira, Takayuki Kaburagi · 2021 · Medicina
17. Efficacy of immune checkpoint inhibitor monotherapy in elderly patients with non-small-cell lung cancer
    Toshio Kubo, Eiki Ichihara, Daijiro Harada, Koji Inoue, Keiichi Fujiwara, Sinobu Hosokawa, Daizo Kishino, Haruyuki Kawai, Nobuaki Ochi, Naohiro Oda et al. · 2023 · Respiratory Investigation
18. The clinical features of older patients with lung cancer in comparison with their younger counterparts
    Hirokazu Ogino, Masaki Hanibuchi, Satoshi Sakaguchi, Yuko Toyoda, Toshifumi Tezuka, Hiroshi Kawano, Soji Kakiuchi, Kenji Otsuka, Atsuro Saijo, Masahiko Azuma et al. · 2018 · Respiratory Investigation
19. Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014
    Yusuke Takagi, Yukio Hosomi, Fumihiro Oshita, Hiroaki Okamoto, Nobuhiko Seki, Koichi Minato, Hiromi Aono, Kouzo Yamada, Yusuke Okuma, Naoya Hida et al. · 2015 · BMC Cancer
20. Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015
    Toshiyuki Kozuki, Naoyuki Nogami, Hiromoto Kitajima, Shunichiro Iwasawa, Emiko Sakaida, Yuichi Takiguchi, Satoshi Ikeda, Masahiro Yoshida, Terufumi Kato, Shingo Miyamoto et al. · 2016 · BMC Cancer
21. Single-Agent Chemotherapy for the Treatment of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: What Is the Best Drug?
    Cesare Gridelli, Paolo Maione, Antônio Rossi · 2007 · Journal of Clinical Oncology
22. [Consensus of Chinese Experts on Medical Treatment of Advanced Lung Cancer in the Elderly (2022 Edition)].
    2022 · PubMed Central
23. Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer
    Satoshi Wasamoto, Hisao Imai, Takeshi Tsuda, Yoshiaki Nagai, Takayuki Kishikawa, Akihiro Ono, Ken Masubuchi, Yukihiro Umeda, Yutaka Yamada, Junichi Nakagawa et al. · 2024 · Internal Medicine
24. Dose Escalation and Pharmacokinetic Study of Carboplatin plus Pemetrexed for Elderly Patients with Advanced Nonsquamous Non-Small-Cell Lung Cancer: Kumamoto Thoracic Oncology Study Group Trial 1002
    Shinya Sakata, Jiichiro Sasaki, Sho Saeki, Akinobu Hamada, Hiroto Kishi, Kazuyoshi Nakamura, Hideyuki Tanaka, Daisuke Notsute, Ryo Sato, Koichi Saruwatari et al. · 2014 · Oncology
25. Phase I and II Trials of Vinorelbine With Carboplatin for Patients 75 Years of Age or Older With Previously Untreated Non–Small-Cell Lung Cancer
    Hiroshi Takatani, Yoichi Nakamura, Seiji Nagashima, Hiroshi Soda, Akitoshi Kinoshita, Minoru Fukuda, Masaaki Fukuda, Yoshifumi Soejima, Takashi Kasai, Katsumi Nakatomi et al. · 2012 · Clinical Lung Cancer
26. Prognostic factors in older patients with wild-type epidermal growth factor receptor advanced non-small cell lung cancer: a multicenter retrospective study
    Yurie Seto, Yoshiko Kaneko, Takako Mouri, Hiroyuki Fujii, Satomi Tanaka, Shinsuke Shiotsu, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Tadaaki Yamada et al. · 2021 · Translational Lung Cancer Research
27. Real-world clinical practice for advanced non-small-cell lung cancer in the very elderly: A retrospective multicenter analysis
    Takahiro Fukushima, Yoshitaka Oyamada, Shinnosuke Ikemura, Shigenari Nukaga, Takashi Inoue, Daisuke Arai, Keiko Ohgino, Aoi Kuroda, Kota Ishioka, Fumio Sakamaki et al. · 2022 · Clinical Lung Cancer
28. Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations
    Gunma-Ibaraki-Fukushima-Tochigi (GIFT) Group, Hisao Imai, Hiroyuki Minemura, Tomohide Sugiyama, Yutaka Yamada, Kyoichi Kaira, Kenya Kanazawa, Takashi Kasai, Takayuki Kaburagi, Koichi Minato · 2018 · Cancer Chemotherapy and Pharmacology
29. A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
    Motoko Yoshikawa TACHIHARA, Tatsunori Kiriu, Akito Hata, Yukihisa Hatakeyama, Kyosuke Nakata, Tatsuya Nagano, Masatsugu Yamamoto, Kazuyuki Kobayashi, Hisashi Ohnishi, Nobuyuki Katakami et al. · 2019 · Cancer Management and Research
30. Microwave ablation or plus monochemotherapy in elderly advanced non-small-cell lung cancer patients
    Zhigang Wei, Qingyu Li, Xin Ye, Xia Yang, Guanghui Huang, Wenhong Li, Jiao Wang, Xiaoying Han · 2019 · Minimally Invasive Therapy & Allied Technologies
31. Short‐Term Efficacy of Different First‐Line Chemotherapy Regimens for Advanced Non‐Small Cell Lung Cancer: A Network Meta‐Analysis
    Bei‐Bei Zhang, Weibo Zhu, Jun Tao, Yun Li, Chuan‐Chong Du, Yun‐Xia Chen, Yuanhua Liu · 2020 · Clinical and Translational Science
32. Cancer bronchique du sujet âgé
    Gilles Albrand, Elisabeth Biron, I. Boucot, L.J. Couderc, Bruno Crestani, Marie-Christine Dombret, Hervé Jean-Pierre Guénard, Michel Grivaux, Marie Pierre Hervy, BRUNO HOUSSET et al. · 2007 · Revue des Maladies Respiratoires
33. A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer
    Taizo Hirata, Shinji Ozaki, Masahiro Tabata, Takayuki Iwamoto, Shiro Hinotsu, Akinobu Hamada, Takayuki Motoki, Tomohiro Nogami, Tadahiko Shien, Naruto Taira et al. · 2020 · Internal Medicine
34. Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients
    Pasquale Comella, Carlo Putzu, B. Massidda, Giovanni Condemi, Giuseppe De Cataldis, Enrico Barbato, Antonio Gambardella, Antonio Avallone, Luca Franco · 2007 · Lung Cancer
35. Treatment of Lung Cancer in Older Patients
    Lynn T. Tanoue, Scott N. Gettinger · 2007 · Clinics in Chest Medicine
36. Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Hiroaki Takeoka, Kazuhiko Yamada, Koichi Azuma, Yoshiaki Zaizen, Fumie Yamashita, Tsukasa Yoshida, Yoshiko Naito, Yusuke Okayama, Maki Miyamoto, Tomoaki Hoshino · 2014 · Japanese Journal of Clinical Oncology
37. Challenges associated with systemic therapy for older patients with inoperable non-small cell lung cancer
    Connor Gerard O’Leary, Lynda M. McSorley, Bryan T. Hennessy, Liam Grogan, Oscar S. Breathnach, Patrick Glyn Morris · 2020 · Expert Opinion on Pharmacotherapy
38. A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations ( JMTO LC12 ‐01)
    Kazuhiro Asami, Masahiko Ando, Takashi Nishimura, Takashi Yokoi, Atsuhisa Tamura, Koichi Minato, Masahide Mori, Fumitaka Ogushi, Akiyoshi Yamamoto, Hiroshige Yoshioka et al. · 2022 · Thoracic Cancer
39. Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer
    Yusuke Chihara, Koji Date, Yoshizumi Takemura, Nobuyo Tamiya, Yoshihito Kohno, Tatsuya Imabayashi, Yoshiko Kaneko, Tadaaki Yamada, Mikio Ueda, 太一郎 有本 et al. · 2018 · Investigational New Drugs
40. ＜Editors' Choice＞ Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group.
    Masataka Sawaki, Kenji Tamura, Akihiko Shimomura, Yumiko Taki, Fumio Nagashima, Hiroji Iwata · 2018 · Europe PMC (PubMed Central)
41. Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer
    Takeshi Masuda, Kazunori Fujitaka, Nobuhisa Ishikawa, Kikuo Nakano, Masahiro Yamasaki, Souichi Kitaguchi, Ken Masuda, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu et al. · 2020 · Journal of Thoracic Disease
42. Elderly lung cancer patients: what treatment strategies?
    Cesare Gridelli · 2007 · Expert Review of Anticancer Therapy
43. Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)
    Nasser H. Hanna · 2007 · Yearbook of Oncology
44. Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?
    Toshio Katô, Masahiro Morise, Masahiko Ando, Eiji Kojima, Tomohiko Ogasawara, Ryujiro Suzuki, Joe Shindoh, Masami Matsumoto, Yasuteru Sugino, Masahiro Ogawa et al. · 2016 · Journal of Cancer Research and Clinical Oncology
45. Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer
    Kyoichi Kaira, Noriko Yanagitani, Noriaki Sunaga, Hisao Imai, Akihiro Ono, Yasuhiko Koga, Takeshi Hisada, Tamotsu Ishizuka, Masanobu Yamada · 2017 · Oncology Letters
46. A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Akihiro Yoshimura, Yusuke Chihara, Koji Date, Nobuyo Tamiya, Yoshizumi Takemura, Tatsuya Imabayashi, Yoshiko Kaneko, Tadaaki Yamada, Mikio Ueda, 太一郎 有本 et al. · 2018 · The Oncologist
47. The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma
    Jong Hyun Choi, Juwhan Choi, Sang Mi Chung, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Jae Jeong Shim, Kyung Ho Kang, Hyun Kyung Lee et al. · 2018 · Tuberculosis & respiratory diseases
48. Comparison of efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis.
    Gaëtan Des Guetz, Bernard Uzzan, Patrick Nicolas, Kader Chouahnia, Gérard Yves Perret, Georges Sebbane, Jean‐François Morère · 2010 · Journal of Clinical Oncology
49. Real world results of locally advanced and metastatic lung cancer patients treated with platinum doublet chemotherapy in first line: Moroccan cohort
    Hassan Abdelilah Tafenzi, Farah Choulli, Edwin Kelly Haag, Anass Baladi, Ismail Essaadi, Rhizlane Belbaraka · 2024 · Translational Oncology
50. Management of Metastatic Nonsmall Cell Lung Cancer in Elderly
    Hardik Sheth, Prashant Kumar, Sewanti Atul Limaye · 2021 · Indian Journal of Medical and Paediatric Oncology
51. Survival benefit and potential markers of chemotherapy for elderly and poor performance status patients with advanced non-small cell lung cancer: Results from the Japanese Joint Committee of lung cancer registry database
    Satoshi Ikeda, Takashi Ogura, Etsuo Miyaoka, Ikuo Sekine, Takehito Shukuya, Koichi Takayama, Akira Inoue, Isamu Okamoto, Masahiro Seike, Kazuhisa Takahashi et al. · 2025 · Lung Cancer
52. Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Yongshun Chen, Qinglian Wen, HAO LIU, Rui Ao, Xiao‐Yuan Wu, Leiming Guo, Wen Wang, Chunyu He, Jianhua Wang · 2013 · Molecular and Clinical Oncology
53. Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L)
    Motoko Yoshikawa TACHIHARA, Akito Hata, Takaaki Tokito, Satoshi Hara, Hideaki Okada, Satoru Miura, Yuki Sato, Eriko Tabata, Hiroshi Watanabe, Yusuke Takayama et al. · 2023 · JTO Clinical and Research Reports
54. Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non–small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L)
    Akito Hata, Nobuyuki Katakami, Mototsugu Shimokawa, Tetsuya Mitsudomi, Nobuyuki Yamamoto, Kazuhiko Nakagawa · 2018 · Clinical Lung Cancer
55. Lung Cancer in Elderly
    Anne Dagnault, Jean Archambault · 2012 · InTech eBooks
56. Safety and efficacy of single‐agent docetaxel ( T axotere) administered weekly in non‐small cell lung carcinoma patients in K orea: An observational study
    Sun Min Lim, Byeong Bae Park, Keunchil Park, Hoon-Kyo Kim, Jong Seok Lee, Sung Hwa Bae, Seung‐Sei Lee, Jin‐Hyoung Kang, Se‐Hoon Park, Gyeong‐Won Lee et al. · 2015 · Thoracic Cancer
57. UFT Plus Vinorelbine in Advanced Non-small Cell Lung Cancer: A Phase I and an Elderly Patient-Directed Phase II Study
    Tadashi Igishi, Yasushi Shigeoka, Kazuhito Yasuda, Hisashi Suyama, Satoru Katayama, 明則 杉谷, Shingo Matsumoto, Mitsunobu Yamamoto, Yasuto Ueda, Ken’ichi Takeda et al. · 2009 · Journal of Thoracic Oncology
58. Doublets versus single-agent therapy as first-line therapy for elderly patients with advanced non-small cell lung cancer? A systematic review of randomised controlled trials
    XU Chong-an, Z.-Y. Chang, Xue-Lian Wang, H.-Y. Qi · 2013 · International Journal of Clinical Practice
59. Age-Related Genetic Abnormalities: The Achilles‘ Heel for Customizing Therapy in Elderly Lung Cancer Patients
    Rafael Rosell, Mariacarmela Santarpía, Teresa Morán, Maria Salazar, Diego Lucas Kaen, José Luis Ramírez · 2007 · Personalized Medicine
60. Delayed onset, Long-term Efficacy of S-1 Monotherapy for an Elderly Patient with Squamous Cell Lung Cancer
    Nobuhiro Kanaji Nobuki Nanki · 2014 · Chemotherapy Open access
61. Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer
    Masafumi Yamaguchi, Hideki Hirata, Noriyuki Ebi, Jun Araki, Takashi Seto, Riichiroh Maruyama, Shinji Akamine, Yuichi Inoue, Hiroshi Semba, Jiichiro Sasaki et al. · 2019 · Japanese Journal of Clinical Oncology
62. Does progress achieved in the treatment of patients with metastatic non‐small‐cell lung cancer reach the elderly population? A cohort study from a cancer centre from Eastern Switzerland
    Sabine Schmid, Jorūnė Šuipytė, C. Herrmann, Seyed Mohsen Mousavi, Felicitas Hitz, Martin Früh · 2020 · European Journal of Cancer Care
63. Spécificités de la prise en charge du CBNPC chez les sujets âgés
    R. Corre, H. Le Caer · 2016 · ONCOLOGIE
64. Treatment selection pattern and prognostic factors in older patients with non-small cell lung cancer at recurrence: an observational study
    Dai Sonoda, Raito Maruyama, Yasuto Kondo, Masahito Naito, Masashi Mikubo, Kazu Shiomi, Yukitoshi Satoh · 2024 · Surgery Today
65. Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
    Satoshi Endo, Hisao Imai, Atsuto Mouri, Kasumi Tsukamoto, Kenji Masaki, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Junichi Nakagawa et al. · 2025 · Journal of Cancer Research and Clinical Oncology
66. Spezielle Aspekte bezogen auf Organsysteme nach geriatrisch-klinischer Bedeutung
    Martin Wehling, Heinrich Burkhardt, Stefan Theodor Schwarz, Lutz Frölich, Ulrich Wedding · 2016 · Springer eBooks
67. Treatment of Advanced Non Small Cell Lung Cancer in Routine Care: A Retrospective Analysis of 212 Consecutive Patients Treated in a Community Based Oncology Group Practice
    H. F. Koeppler, Jochen Heymanns, Joerg Thomalla, Kristina Kleboth, Ulrike Mergenthaler, Rudolf Weide · 2009 · Clinical medicine Oncology
68. [Anticancer chemotherapy in the elderly: a review of the literature].
    Isabelle Debrix, Danièle Avenin, Thierry André, Fadi Abbas, Joseph Gligorov, Bernard J. Milleron, Jean‐Pierre Lotz, Annie Becker · 2008 · PubMed
69. Defining the Issues in the Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer
    Ajeet Gajra · 2015 · Lung Cancer Management
70. Quelles options pour la chimiothérapie de première ligne des CBNPC de stade IV ?
    P. Fournel · 2009 · Revue des Maladies Respiratoires
71. Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer
    Jin Ho Baek, Hawk Kim, Jong‐Joon Ahn, Yangjin Jegal, Kwang Won Seo, Seung Hwan Won, Chang Ryul Park, Jong Pil Jung, Jeong Won Kim, Yong Jik Lee et al. · 2011 · Lung Cancer
72. Cancer bronchique non à petites cellules métastatique : les traitements systémiques des sujets de plus de 70ans
    Élisabeth Quoix, A Ducoloné, B. Mennecier, Philippe Fraisse · 2011 · La Presse Médicale
73. Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care
    Toshihide Nishimura, Harubumi Kato, Norihiko Ikeda, Makoto Kihara, Masaharu Nomura, Yasufumi Kato, György Marko‐Varga · 2012 · International Journal of Proteomics
74. Targeted therapies in the treatment of advanced non-small cell lung cancer elderly patients
    Cesare Gridelli, Paolo Maione, Antônio Rossi, Carmine Ferrara, G. Colantuoni, Filomena Del Gaizo, Dario Nicolella, Ciro Guerriero · 2006 · Targeted Oncology
75. Overview of Clinical Trials for Lung Cancer in the Elderly
    Cesare Gridelli, Antônio Rossi, Paolo Maione, Giovanni Palazzolo, Paola Claudia Sacco, Maria Anna Bareschino, Clorinda Schettino · 2008 · Aging Health
76. A retrospective analysis comparing the safety and efficacy of chemotherapy in elderly and non‐elderly non‐small‐cell lung cancer patients
    Yukari Tsubata, Takeshi Honda, Tamio Okimoto, Kiyotaka Miura, Fumi Karino, Shinichi Iwamoto, Taeko Suzuki, Shunichi Hamaguchi, Hibiki Kanda, Akihisa Sutani et al. · 2012 · Geriatrics and gerontology international/Geriatrics & gerontology international
77. Advanced non-small cell lung cancer in elderly patients
    Élisabeth Quoix · 2012 · Breathe
78. High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study
    Xiaorong Ma, Yan Xu, Wanggang Zhang, Jin Wang, Xing-Mei Cao, Yinxia Chen, Aili He, Jie Liu, JianLi Wang, Wanhong Zhao et al. · 2016 · Medical Science Monitor
79. Designing geriatric-specific trials in advanced lung cancer: What, who and how to study?
    Ajeet Gajra · 2016 · Journal of Geriatric Oncology
80. Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged ≥75 years with squamous-cell lung cancer: TORG1322
    Yoshitaka Zenke, Seiji Niho, Shigeki Umemura, Masashi Ishihara, Nobuhiko Seki, Naoyuki Nogami, Yukio Hosomi, Tsuneo Shimokawa, Takaaki Tokito, Yasushi Goto et al. · 2020 · Lung Cancer
81. Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non‐squamous non‐small cell lung cancer: A single‐arm, open‐label, multicenter, phase II study
    Masahiro Shinoda, Masaharu Shinkai, Yu Hara, Kouji Tomaru, Saki Manabe, Syuji Murakami, Haruhiro Saito, Nobuaki Kobayashi, Naoki Miyazawa, Masanori Nishikawa et al. · 2021 · Asia-Pacific Journal of Clinical Oncology
82. A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer
    Yohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu, Naoki Nishimura, Yuko Toyoda, Atsushi Mitsuhashi, Kenji Otsuka, Seidai Sato et al. · 2023 · Thoracic Cancer
83. Docetaxel As Monotherapy in the Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients
    Ashok Kumar Malani, Rony M. Abou-Jawde, Jaswinder Singh, Sarah A. Taylor · 2007 · Journal of Clinical Oncology
84. [A meta analysis of doublets versus single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer].
    XU Chong-an, Ziyou Chang, Xiaojie Wang, Lin Li, Haiyan Qi, Yan Liu · 2012 · Europe PMC (PubMed Central)
85. Pharmacotherapy Update: Vinorelbine in the Treatment of non-small-cell Lung cancer
    Jean Trédaniel, Lionel Staudacher, Luís Teixeira, Sihem Sebbagh, Sébastien Bucquet, Christophe Hennequin · 2010 · Clinical Medicine Insights Therapeutics
86. Concurrent chemoradiotherapy with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts
    Lin‐Wei Wang, Xing Huang, Xiaodong Zheng, Xinghuan Wang, Shi-Pian Li, L-P Zhang, Zhonghua Yang · 2013 · Clinical & Translational Oncology
87. Chemotherapy (Gemcitabine plus Carboplatin versus Paclitaxel plus Carboplatin) in Elderly Patients with Non-Small Cell Lung Cancer
    Takanori Ayabe, Masaki Tomita, Eiichi Chosa, Makoto Ikenoue, Yukie Shirasaki, Kunihide Nakamura · 2014 · Journal of Cancer Therapy
88. A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905
    Takayasu Kurata, Tomonori Hirashima, Yasuo Iwamoto, Tomoya Kawaguchi, Norihiko Ikeda, Masahiro Tsuboi, Toshiyuki Sawa, Takashi Ishiguro, Takuya Aoki, Yoshikazu Kotani et al. · 2012 · Lung Cancer
89. Elderly Patients with Advanced Non-Small Cell Lung Cancer: What Treatment?
    Antônio Rossi · 2011 · The Open Lung Cancer Journal
90. Treatment Decisions and Medical Treatment of Cancer in Elderly Patients
    Ulrich Wedding, Stuart M. Lichtman · 2012 · Springer eBooks
91. Management of elderly patients.
    Alain Vergnenégre, R. Corre, H. Léna, H. Le Caer · 2013 · Europe PMC (PubMed Central)
92. Analysis of the Risk Factors for Severe Neutropenia in Advanced Non-Small Cell Lung Cancer after the First Course of Chemotherapy with Third-Generation Agents
    M Shibuya, Mari Kogo, Tatsuya Kurihara, Yusuke Shikama, Hiroaki Nakajima, Keiichiro Yoneyama, Yuji Kiuchi · 2013 · YAKUGAKU ZASSHI
93. Non-small cell lung cancer therapy in the elderly.
    Cesare Gridelli, Antônio Rossi, Paolo Maione, Clorinda Schettino, Maria Anna Bareschino, Giovanni Palazzolo, Rosario Zeppa, Rita Ambrosio, Valentina Barbato, Paola Claudia Sacco · 2011 · PubMed
94. A phase II study of carboplatin and pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer
    Hironari Nishizawa, Atsushi Horiike, Ryota Saito, Fumiyoshi Ohyanagi, Keita Kudo, Noriko Yanagitani, Yuichi Tambo, Satoru Kitazono, Hiroshi Kobayashi, Makoto Nishio · 2016 · Cancer Treatment and Research Communications
95. The Therapeutic Approaches Applied in the Treatment of Non-small Cell Lung Cancer in Elderly Patients
    Masafumi Yamaguchi · 2017 · Haigan
96. The most-cited articles in geriatric oncology: a bibliometric analysis
    Okan Avcı, S. Seber · 2021 · Współczesna Onkologia
97. Traitement du cancer bronchique chez le sujet âgé
    R. Corre, Élisabeth Quoix · 2023 · Revue des Maladies Respiratoires Actualités
98. Palliative Care, Advance Care Planning, and Craftsmanship: What He Taught Me Through End-of-Life Care
    Tadashi Nishimura, Megumi Nakamura, Jun Kako, Hajime Fujimoto · 2025 · Journal of Palliative Medicine
99. Management of lung cancer in older adults
    Suresh S. Ramalingam, Chandra Prakash Belani · 2010 · Cambridge University Press eBooks
100. Efficacy and Safety of Docetaxel in the Elderly
     Supriya Gupta Mohile, Farid Berenji, Deepak M. Sahasrabudhe, Gary R. Morrow, Daniel Peter Petrylak · 2008 · Aging Health